Buerger's disease historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 33: Line 33:
{{WH}}
{{WH}}
{{WS}}
{{WS}}


[[Category:Cardiovascular diseases]]
[[Category:Cardiovascular diseases]]
Line 39: Line 38:
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
[[Category:Up-To-Date]]

Revision as of 15:41, 9 April 2018

Buerger's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Buerger's Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Buerger's disease historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Buerger's disease historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Buerger's disease historical perspective

CDC on Buerger's disease historical perspective

Buerger's disease historical perspective in the news

Blogs on Buerger's disease historical perspective

Directions to Hospitals Treating Buerger's disease

Risk calculators and risk factors for Buerger's disease historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Historical Perspective

Buerger's disease was first reported by Felix Von Winiwater in 1879 in Germany.[1]

It was described in detail by Leo Buerger in 1908 in New York,[2] who called it presenile spontaneous gangrene after studying amputations in 11 patients.

Overview

Historical Perspective

Discovery

  • [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
  • The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
  • In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
  • In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].

Outbreaks

  • There have been several outbreaks of [disease name], which are summarized below:

Landmark Events in the Development of Treatment Strategies

  • In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].

Impact on Cultural History

Famous Cases

References

  1. von Winiwarter F: Ueber eine eigenthumliche Form von Endarteriitis und Endophlebitis mit Gangran des Fusses. Arch Klin Chir 1879; 23: 202-26.
  2. Buerger L. Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908;136:567-80.

Template:WH Template:WS